To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC77996 | Vasoactive intestinal peptide |
Vasoactive intestinal peptide is an agonist of VPAC1/VPAC2 receptor (G-protein-coupled receptors). Vasoactive intestinal peptide reduces corneal perforation rate, bacterial load, and excessive neutrophil infiltration in Pseudomonas aeruginosa-induced keratitis models. Vasoactive intestinal peptide enhances anti-inflammatory mediators like IL-10 and TGF-β, inhibites pro-inflammatory factors such as IL-1β and TNF-α, and upregulates lipid mediator-related enzymes (SOCS3, COX-2, ALOX12) to promote inflammation resolution. Vasoactive intestinal peptide is promising for research of ocular infectious diseases.
More description
|
|
| DC77989 | Superoxide dismutase PEG |
Superoxide dismutase PEG (EC 1.15.1.1) is a mimetic of superoxide dismutase (SOD) and powerful free radical scavenger acts by reducing superoxide anions.
More description
|
|
| DC77987 | Solbinsiran |
Solbinsiran is a siRNA targeted to hepatic ANGPTL3.
More description
|
|
| DC77986 | Solbinsiran sodium |
Solbinsiran sodium is a siRNA targeted to hepatic ANGPTL3.
More description
|
|
| DC77983 | Senvesiran |
Senvesiran, a siRNA, is a ketohexokinase synthesis reducer.
More description
|
|
| DC77982 | Senvesiran sodium |
Senvesiran sodium, a siRNA, is a ketohexokinase synthesis reducer.
More description
|
|
| DC77979 | scrambled IONIS-MAPTRx sodium |
Scrambled IONIS-MAPTRx (sodium) is a scrambled sequence of IONIS-MAPTRx sodium. Scrambled IONIS-MAPTRx (sodium) has the same amino acid composition as the active IONIS-MAPTRx sodium fragment, but the sequence is randomly scrambled. Scrambled IONIS-MAPTRx (sodium) is typically used as a negative control. Scrambled IONIS-MAPTRx (sodium) has potential for studying Alzheimer's disease.
More description
|
|
| DC77977 | Sapablursen |
Sapablursen, an antisense oligonucleotide, is designed to reduce the production of TMPRSS6 resulting in increased expression of hepcidin, which is the key regulator of iron homeostasis. Sapablursen can be used in the research of blood diseases such as pol
More description
|
|
| DC77976 | Sapablursen sodium |
Sapablursen sodium, an antisense oligonucleotide, is designed to reduce the production of TMPRSS6 resulting in increased expression of hepcidin, which is the key regulator of iron homeostasis. Sapablursen sodium can be used in the research of blood diseas
More description
|
|
| DC77974 | Rimigorsen |
Rimigorsen is an antisense oligonucleotide that induces skipping of exon 44 of the pre-mRNA encoding dystrophin in a Duchenne muscular dystrophy (DMD)
More description
|
|
| DC77973 | Rimigorsen sodium |
Rimigorsen sodium is an antisense oligonucleotide that induces skipping of exon 44 of the pre-mRNA encoding dystrophin in a Duchenne muscular dystrophy (DMD)
More description
|
|
| DC77972 | Renadirsen |
Renadirsen is an antisense oligonucleotide that induces robust Exon 45 skipping for Dystrophin in vivo.
More description
|
|
| DC77971 | Renadirsen sodium |
Renadirsen sodium is an antisense oligonucleotide that induces robust Exon 45 skipping for Dystrophin in vivo.
More description
|
|
| DC77970 | Pixofisiran |
Pixofisiran is a siRNA in STP705. It targets to TGF‐β1. STP705 is composed of 2 siRNA oligonucleotides (Pixofisiran and Lixadesiran) that individually target TGF-β1 and COX-2 mRNA.
More description
|
|
| DC77969 | Pixofisiran sodium |
Pixofisiran sodium is a siRNA in STP705. It targets to TGF‐β1. STP705 is composed of 2 siRNA oligonucleotides (Pixofisiran and Lixadesiran) that individually target TGF-β1 and COX-2 mRNA.
More description
|
|
| DC77968 | Pivicasiran |
Pivicasiran, a siRNA, is a adiponutrin synthesis reducer.
More description
|
|
| DC77967 | Pivicasiran sodium |
Pivicasiran sodium, a siRNA, is a adiponutrin synthesis reducer.
More description
|
|
| DC77960 | Opemalirsen |
Opemalirsen is an antisense oligonucleotide targeted to apolipoprotein L1 (APOL1). It is used for the study of Kidney disorders.
More description
|
|
| DC77959 | Opemalirsen sodium |
Opemalirsen sodium is an antisense oligonucleotide targeted to apolipoprotein L1 (APOL1). It is used for the study of Kidney disorders.
More description
|
|
| DC77958 | Onvuzosiran |
Onvuzosiran, a siRNA, is a prekallikrein synthesis reducer.
More description
|
|
| DC77957 | Onvuzosiran sodium |
Onvuzosiran sodium, a siRNA, is a prekallikrein synthesis reducer.
More description
|
|
| DC77951 | FAPI-P8PN |
FAPI-P8PN is a fibroblast activation protein (FAP) inhibitor (IC50=3.6 nM). FAPI-P8PN is promising for research of FAP-overexpressing solid tumors.
More description
|
|
| DC77950 | OZO-H |
OZO-H is a GST inhibitor. OZO-H is an OZO derivative with potent anti-cancer effects. OZO-H releases JNK1 from GST-JNK1 complex. OZO-H induces JNK1 phosphorylation and activates c-Jun in cancer cells.
More description
|
|
| DC77949 | OZO-Cl |
OZO-Cl is an OZO derivative. OZO-Cl has anti-cancer activity. OZO-Cl significantly decreases the intracellular glutathion S-transferase Pi (GST) activity. OZO-Cl exhibits cytotoxicity to cancer cell lines, with IC50s of 150 and 120 μmol/L in Panc-1 and K562 cells respectively.
More description
|
|
| DC77945 | Nucresiran |
Nucresiran is a siRNA that inhibits hepatic synthesis of both wild-type and variant TTR mRNA.
More description
|
|
| DC77944 | Nucresiran sodium |
Nucresiran sodium is a siRNA that inhibits hepatic synthesis of both wild-type and variant TTR mRNA.
More description
|
|
| DC77943 | Nivudirsen |
Nivudirsen is an antisense oligonucleotide that can promote the synthesis of functional dystrophin protein.
More description
|
|
| DC77942 | Nivudirsen sodium |
Nivudirsen sodium is an antisense oligonucleotide that can promote the synthesis of functional dystrophin protein.
More description
|
|
| DC77937 | FBnG-amino-PEG3-C2-azido |
FBnG-amino-PEG3-C2-azido is a tag-linker conjugate that incorporates a degradation tag FBnG and a glycol linker (Amino-PEG3-C2-Azido). FBnG-amino-PEG3-C2-azido can be used for synthesis of GPX4-AUTAC
More description
|
|
| DC77936 | Duazomycin sodium |
Duazomycin (Duazomycin A) sodium is a glutamine antagonist. Duazomycin sodium can significantly enhance the effectiveness of 6-Mercaptopurine (6-MP) in experimental allergic encephalomyelitis (EAE) without increasing toxicity.
More description
|
|